Castration-Resistant Prostate Carcinoma

general

A prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production.

87

Centers

369

Active Trials

$3.7B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Castration-Resistant Prostate Carcinoma(87)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.6
2
High-Volume Research Center
72.6
370.7
4
NCI Comprehensive
High-Volume Research Center
70.7
5
NCI Comprehensive
High-Volume Research Center
70.7
6
High-Volume Research Center
70.7
7
NCI Comprehensive
Active Research Program
67.6
8
NCI Comprehensive
Active Research Program
67.6
9
NCI Comprehensive
Active Research Program
67.6
10
NCI Comprehensive
Active Research Program
67.6
11
NCI Clinical
Active Research Program
67.6
12
NCI Comprehensive
Active Research Program
67.6
13
NCI Comprehensive
Active Research Program
61.5
14
NCI Comprehensive
Active Research Program
61.5
15
NCI Comprehensive
Active Research Program
61.5
16
NCI Comprehensive
Active Research Program
61.5
17
NCI Comprehensive
Active Research Program
61.5
18
NCI Comprehensive
Active Research Program
61.5
19
Active Research Program
61.5
20
Active Research Program
61.5
21
NCI Clinical
Active Research Program
61.5
22
NCI Clinical
Active Research Program
61.5
23
Active Research Program
61.5
2461.5
25
Active Research Program
61.5
26
Active Research Program
61.5
27
NCI Comprehensive
Active Research Program
52.5
28
NCI Comprehensive
Active Research Program
52.5
29
NCI Comprehensive
Active Research Program
52.5
30
NCI Comprehensive
Active Research Program
52.5
31
NCI Comprehensive
Active Research Program
52.5
32
NCI Comprehensive
Active Research Program
52.5
33
NCI Comprehensive
Active Research Program
52.5
34
NCI Comprehensive
Active Research Program
52.5
35
NCI Comprehensive
Active Research Program
52.5
36
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
52.5
37
Active Research Program
52.5
38
Active Research Program
52.5
39
Active Research Program
52.5
40
Active Research Program
52.5
41
Active Research Program
52.5
42
NCI Comprehensive
Active Research Program
39.3
43
NCI Comprehensive
Active Research Program
39.3
44
NCI Comprehensive
Active Research Program
39.3
45
NCI Comprehensive
Active Research Program
39.3
46
NCI Comprehensive
Active Research Program
39.3
47
NCI Comprehensive
Active Research Program
39.3
48
NCI Comprehensive
Active Research Program
39.3
49
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
39.3
50
NCI Comprehensive
Active Research Program
39.3
51
NCI Comprehensive
Active Research Program
39.3
52
NCI Comprehensive
Active Research Program
39.3
53
NCI Clinical
Active Research Program
39.3
54
NCI Comprehensive
Active Research Program
39.3
55
NCI Comprehensive
Active Research Program
39.3
56
NCI Comprehensive
Active Research Program
39.3
57
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
39.3
58
Active Research Program
39.3
59
NCI Comprehensive
Active Research Program
39.3
60
NCI Comprehensive
Active Research Program
39.3
61
NCI Comprehensive
Active Research Program
39.3
62
NCI Comprehensive
Active Research Program
39.3
63
Active Research Program
39.3
64
NCI Basic_laboratory
Active Research Program
39.3
65
Active Research Program
39.3
6639.3
67
Active Research Program
39.3
68
Active Research Program
39.3
69
Active Research Program
39.3
70
NCI Comprehensive
29.4
71
NCI Comprehensive
29.4
72
NCI Comprehensive
29.4
7329.4
74
75
NCI Comprehensive
76
NCI Comprehensive
77
78
NCI Comprehensive
79
NCI Clinical
80
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
81
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
82
83
84
85
86
BC CancerVancouver, BC
87

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →